Methamphetamine use in Australia

Methamphetamine Use in Australia

Methamphetamine, commonly referred to as 'meth', is a powerful, highly addictive stimulant that affects the central nervous system. In Australia, methamphetamine use has been a significant public health issue, with increasing rates of use and associated harms.

History

Methamphetamine was first synthesized in Japan in 1893. It was used extensively during World War II to keep soldiers awake. In Australia, methamphetamine use began to rise in the late 1990s, with a significant increase in the early 2000s.

Prevalence

According to the 2019 National Drug Strategy Household Survey, approximately 6.4% of Australians aged 14 years and over have used methamphetamine at least once in their lifetime. The use of methamphetamine in Australia is more prevalent among males and those aged 20-29 years.

Effects on Health

Methamphetamine use can have severe health effects, including mental health problems, cardiovascular disease, and increased risk of infectious diseases such as HIV and hepatitis. Long-term use can lead to methamphetamine use disorder, a severe form of substance use disorder.

Government Response

The Australian government has implemented various strategies to address methamphetamine use, including law enforcement, prevention, treatment, and harm reduction strategies. The National Ice Action Strategy, launched in 2015, is a key component of this response.

Treatment

Treatment for methamphetamine use in Australia includes pharmacological and psychosocial interventions. Pharmacological treatments include medications to manage withdrawal symptoms, while psychosocial treatments include cognitive-behavioral therapy and contingency management.

See Also

• Drug policy of Australia
• Substance use disorder
• Harm reduction